Advancing Precision Oncology With the Syapse Precision Medicine Council

In June, Syapse—a company that works with health systems to implement precision medicine across its organizations—took the next step in leading the shift toward precision medicine by launching the Syapse Precision Medicine Council. The council consists of oncology, operations, and research leaders from health systems dedicated to advancing precision medicine through sharing strategies and insights in order to identify best practices.

Dennis Shin, chief commercial officer of Syapse, discussed the formation of the council, how it plans to disrupt the current precision oncology landscape, and what he sees for the future of the council.

To listen, login to the website.

Listen above or through one of these podcast services:

iTunes: http://apple.co/2eYWTss?rel=0"

TuneIn: http://bit.ly/2gv7iwj?rel=0"

Stitcher: http://bit.ly/2gCqtFg?rel=0"

Syapse, Roche Team Up to Advance Precision Medicine in Oncology

Syapse Looks to Expand Precision Medicine Partnerships With New CEO

Oncologists Are Crucial to Advancing Precision Medicine

Precision Health AI Launches Platform to Deliver Data-Driven Insights in Oncology

Using Health IT to Increase Medication Adherence and Enhance Precision Medicine

Read more about Syapse and precision oncology: